Adel Talaat, MVSc, PhD

Adel Talaat, MVSc, PhD

email: atalaat@wisc.edu
phone: (608) 262-2861

Title(s)

Associate Professor, Department of Pathobiological Sciences, University of Wisconsin-Madison

Office

303 AHABS
1656 Linden Drive
Madison, WI 53706

Information

Education

Postdoctoral training: 1998-2002, University of Texas Southwestern Medical Center, Dallas TX
Ph.D., 1998, University of Maryland School of Medicine, Baltimore MD
M.V.Sc., 1990, Faculty of Veterinary Medicine, Cairo University, Egypt
B.V.Sc., 1986, Faculty of Veterinary Medicine, Cairo University, Egypt

Research interests:

  • Pathogenesis of emerging respiratory infections (e.g. Mycobacterial diseases, Coronaviruses)
  • Vaccine development for animal and human infections.
  • Evolution of bacterial and viral genomes

I am a microbiologist with a long-term interest in better understanding the pathogenesis and control of emerging infectious diseases. I received my veterinary and master’ degrees from Cairo University and a Ph.D. from the School of Medicine University of Maryland At Baltimore. Currently, I am a professor of microbiology at the University of Wisconsin-Madison. My research involves developing new technologies and innovative vaccines against human tuberculosis and bovine paratuberculosis to help the dairy industry. Recently, we started to utilize nanotechnology to develop effective nanovaccines against avian influenza and infectious bronchitis virus to help the poultry industry.

Professor of microbiology. My group works on developing innovative approaches to better understand infectious diseases and to design better vaccines that can improve the health of both animals and humans. Specifically, my group working on mycobacterial diseases to improve animal and human health. Recently, we started to work on developing nanovaccines for avian influenza (AI), infectious bronchitis virus (IBV) for poultry.

Founder and managing CEO of a small start up company in Madison, WI. The company specializes in developing novel approaches for mucosal immunization against mucosal infections including human Mycobacterium tuberculosis, M. avium, human coronavirus (SARS-CoV-2), avian coronavirus (IBV) as well as M. paratuberculosis in cattle.

website